About Us
Founded in 2023, iLab Research Institute is a pioneering non-profit organization committed to addressing some of the most challenging medical conditions facing society today.
Our focus encompasses a broad spectrum of diseases that have historically defied conventional treatment approaches, including cancer, fibrotic diseases, autoimmune disorders, and degenerative diseases of the central nervous system.
Our Mission
At iLab, our mission is to propel the boundaries of medical science by conducting cutting-edge research in critical areas of health. We strive to deepen the understanding of complex diseases, with the ultimate goal of developing preventative strategies and innovative treatments that can dramatically improve patient outcomes.
Research Focus
Our research portfolio is diverse and dynamic, reflecting our commitment to solving the riddles of complex diseases:
Cancer: Investigating the molecular and cellular mechanisms that drive the initiation and progression of various cancers.
Fibrosis: Exploring the pathological processes that lead to fibrotic diseases, aiming to halt or reverse tissue scarring.
Autoimmune Conditions: Unraveling the complexities of the immune system to understand how dysregulation contributes to disease and identifying novel therapeutic targets.
Degenerative CNS Diseases: Studying the decline in central nervous system (CNS) function to develop interventions that can slow, halt, or reverse neurodegenerative processes.
Collaboration and Innovation
iLab thrives on collaboration with leading experts and institutions around the globe. By combining our in-house expertise with that of our partners, we leverage a wide range of innovative research methodologies—from AI and bioinformatics to advanced molecular biology techniques.
This collaborative approach not only enhances our research capabilities but also accelerates the translation of laboratory discoveries into real-world applications.
Commitment to Impact
As a non-profit institution, iLab is dedicated to the public good. Every research breakthrough we achieve is a step towards delivering tangible benefits to patients and communities affected by serious diseases. We are driven by the belief that through rigorous research and collaborative effort, the intractable diseases of today can become the treatable conditions of tomorrow.